BYD July Global Vehicle Sales Rise 22% as Overseas Demand Surges 
Bayer Q2 Earnings Beat Forecasts as Crop Science Boosts Results, Debt Outlook Improves 
Vast Eyes Hong Kong IPO as Chinese AI Unicorn Gains Momentum 
SpaceX Targets Starship Flight 14 With First V3 Starlink Satellite Launch 
Boeing Stock Jumps as FAA Certifies 737 MAX-7 After Years of Regulatory Review 
WestJet Cancels 86 Flights as CUPE Strike Threat Disrupts Travel 
SK Hynix Bonus Dispute Deepens as Union Rejects Stock-Based Payout Proposal 
Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says 
Chery Invests $75 Million in KG Mobility to Expand Global Automotive Partnership 
Capital One Says AML Review Led to Closure of Trump Organization Accounts 
HSBC H1 Profit Jumps 23%, Announces $1 Billion Share Buyback and Reaffirms 2028 Targets 
Palantir Stock Soars as AI Demand Drives Strong Q2 Earnings and Higher 2026 Outlook 
UK AI Security Tests Reveal Anthropic and OpenAI Agents Attempted Unauthorized Actions 
Alibaba Stock Jumps as Qwen 3.8-MAX AI Model Intensifies China's AI Race 
Telegram Restored on Apple App Store After Temporary Removal 
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race 
BHP Port Hedland Strike Set to Proceed as Wage Talks Continue 
NEW YORK, April 02, 2018 -- According to a new research report titled “Psoriasis Therapeutics Pipeline Analysis 2017” published by P&S Market Research, Psoriasis currently exhibits a strong pipeline with 150 drug candidates.
Request for Sample Copy of this Research Report: https://www.psmarketresearch.com/market-analysis/psoriasis-therapeutic-pipeline-analysis/report-sample
The study analyzed that the psoriasis therapeutics pipeline comprises approximately 150 drug candidates in different stages of development. Psoriasis is a chronic inflammatory disorder that causes red patches covered with white scales on the skin. It is characterized when a person’s immune system sends defective signals which results in skin cells to grow rapidly. The body does not shed these excess skin cells and pile up on the surface of the skin, causing patches of psoriasis to appear. There are five types of psoriasis namely, plaque psoriasis or psoriasis vulgaris, guttate psoriasis, inverse psoriasis or flexural psoriasis or intertriginous psoriasis, pustular psoriasis, and erythrodermic or exfoliative psoriasis.
MC2 Therapeutics A/S is using PAD technology platform for the development of MC2-01 for the treatment of psoriasis. PAD technology platform offers a number of unique advantages in the development of new topical drugs. PAD vehicles are special made oil-in-water dispersions in which the internal oil phase is stabilized by encapsulation in a thin yet robust aqueous film of surfactants.
Browse Full Report with detailed TOC on “Psoriasis Therapeutics Pipeline Analysis” at: https://www.psmarketresearch.com/market-analysis/psoriasis-therapeutic-pipeline-analysis
Boehringer Ingelheim GmbH and AbbVie, Inc. entered in a worldwide agreement to develop and commercialize BI 655066, for the treatment of psoriasis.
Some of the key players developing drugs for the treatment of psoriasis include Amgen Inc., Maruho Co., Ltd., Boehringer Ingelheim GmbH and others.
More Reports Published by P&S Market Research
Systemic Lupus Erythematosus Pipeline Analysis - https://www.psmarketresearch.com/market-analysis/systemic-lupus-erythematosus-pipeline-analysis
Amyotrophic Lateral Sclerosis Pipeline Analysis - https://www.psmarketresearch.com/market-analysis/amyotrophic-lateral-sclerosis-pipeline-analysis
About P&S Market Research
P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.
As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.
Contact:
P&S Market Research
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: [email protected]
Web: https://www.psmarketresearch.com
Connect with us: LinkedIn | Twitter | Google + | Facebook
